AAPL331.33-0.01 (0.00%) ▼|ABBV262.23-0.81 (-0.31%) ▼|ABT102.01-0.02 (-0.02%) ▼|ACN189.87-3.54 (-1.83%) ▼|ADBE250.37-7.39 (-2.87%) ▼|AMAT413.30-7.87 (-1.87%) ▼|AMD510.97+6.77 (+1.34%) ▲|AMGN375.69+0.04 (+0.01%) ▲|AMT176.46-1.26 (-0.71%) ▼|AMZN245.21-3.21 (-1.29%) ▼|AVGO338.22-1.05 (-0.31%) ▼|AXP311.49-12.94 (-3.99%) ▼|BA198.29-11.40 (-5.44%) ▼|BAC57.63-1.90 (-3.18%) ▼|BKNG170.65-0.67 (-0.39%) ▼|BLK1,026.70-31.96 (-3.02%) ▼|BMY63.23-0.51 (-0.79%) ▼|BNY152.91-1.76 (-1.14%) ▼|BRK-B518.97+2.21 (+0.43%) ▲|C132.18-4.00 (-2.93%) ▼|CAT779.62-3.92 (-0.50%) ▼|CL86.78-0.22 (-0.25%) ▼|CMCSA23.64-0.78 (-3.20%) ▼|COF201.48-5.38 (-2.60%) ▼|COP132.61-8.62 (-6.10%) ▼|COST894.03-7.32 (-0.81%) ▼|CRM249.94-5.71 (-2.23%) ▼|CSCO107.98-2.09 (-1.90%) ▼|CVS91.61-2.88 (-3.05%) ▼|CVX210.82-6.96 (-3.19%) ▼|DE668.37-15.68 (-2.29%) ▼|DHR208.23-1.13 (-0.54%) ▼|DIS106.59+0.17 (+0.16%) ▲|DUK117.52-0.26 (-0.22%) ▼|EMR145.45-1.55 (-1.05%) ▼|FDX300.53-7.74 (-2.51%) ▼|GD358.75+0.15 (+0.04%) ▲|GE312.44+5.39 (+1.75%) ▲|GEV922.10+39.29 (+4.45%) ▲|GILD147.29+0.99 (+0.67%) ▲|GM84.01-1.36 (-1.59%) ▼|GOOG339.24-2.19 (-0.64%) ▼|GOOGL342.41-2.58 (-0.75%) ▼|GS935.58-41.09 (-4.21%) ▼|HD303.26-2.22 (-0.73%) ▼|HON207.21+3.77 (+1.85%) ▲|IBM236.98-11.40 (-4.59%) ▼|INTC100.14+3.00 (+3.09%) ▲|INTU317.39-11.88 (-3.61%) ▼|ISRG381.58+4.42 (+1.17%) ▲|JNJ267.14-0.07 (-0.02%) ▼|JPM347.37-5.12 (-1.45%) ▼|KO87.88-0.83 (-0.94%) ▼|LIN460.61-2.35 (-0.51%) ▼|LLY1,132.68-3.43 (-0.30%) ▼|LMT534.70+1.24 (+0.23%) ▲|LOW193.97-0.64 (-0.33%) ▼|LRCX267.42-3.45 (-1.27%) ▼|MA567.19-6.08 (-1.06%) ▼|MCD249.70-3.09 (-1.22%) ▼|MDLZ62.44+0.34 (+0.55%) ▲|MDT92.51-1.24 (-1.32%) ▼|META673.07+2.83 (+0.42%) ▲|MMM162.12-2.55 (-1.55%) ▼|MO70.16+0.35 (+0.50%) ▲|MRK144.23+0.44 (+0.31%) ▲|MS201.50-4.78 (-2.32%) ▼|MSFT488.99-8.13 (-1.64%) ▼|MU921.89-5.72 (-0.62%) ▼|NEE80.09-0.99 (-1.22%) ▼|NFLX76.47-1.44 (-1.84%) ▼|NKE35.81-0.42 (-1.15%) ▼|NOW139.27-2.63 (-1.85%) ▼|NVDA213.67+1.50 (+0.71%) ▲|ORCL142.35+2.00 (+1.43%) ▲|PEP134.56-0.94 (-0.69%) ▼|PFE27.40-0.16 (-0.56%) ▼|PG147.28+0.61 (+0.41%) ▲|PLTR172.55-0.01 (0.00%) ▼|PM191.73-2.38 (-1.23%) ▼|QCOM185.52-2.28 (-1.21%) ▼|RTX196.74+1.24 (+0.63%) ▲|SBUX96.89+0.31 (+0.32%) ▲|SCHW105.06-2.73 (-2.53%) ▼|SO85.95+0.00 (+0.00%) ▲|SPG202.04-2.06 (-1.01%) ▼|T25.79-0.93 (-3.48%) ▼|TMO649.40+8.01 (+1.25%) ▲|TMUS173.53-6.94 (-3.85%) ▼|TSLA357.60+1.02 (+0.29%) ▲|TXN259.56-3.87 (-1.47%) ▼|UBER71.36-0.08 (-0.11%) ▼|UNH375.65-0.28 (-0.07%) ▼|UNP280.85-3.14 (-1.11%) ▼|UPS98.65-3.70 (-3.62%) ▼|USB59.62-2.61 (-4.19%) ▼|V369.95-5.68 (-1.51%) ▼|VZ49.60-1.86 (-3.61%) ▼|WFC86.95-2.77 (-3.09%) ▼|WMT107.54-0.55 (-0.51%) ▼|XOM163.34-5.98 (-3.53%) ▼|AAPL331.33-0.01 (0.00%) ▼|ABBV262.23-0.81 (-0.31%) ▼|ABT102.01-0.02 (-0.02%) ▼|ACN189.87-3.54 (-1.83%) ▼|ADBE250.37-7.39 (-2.87%) ▼|AMAT413.30-7.87 (-1.87%) ▼|AMD510.97+6.77 (+1.34%) ▲|AMGN375.69+0.04 (+0.01%) ▲|AMT176.46-1.26 (-0.71%) ▼|AMZN245.21-3.21 (-1.29%) ▼|AVGO338.22-1.05 (-0.31%) ▼|AXP311.49-12.94 (-3.99%) ▼|BA198.29-11.40 (-5.44%) ▼|BAC57.63-1.90 (-3.18%) ▼|BKNG170.65-0.67 (-0.39%) ▼|BLK1,026.70-31.96 (-3.02%) ▼|BMY63.23-0.51 (-0.79%) ▼|BNY152.91-1.76 (-1.14%) ▼|BRK-B518.97+2.21 (+0.43%) ▲|C132.18-4.00 (-2.93%) ▼|CAT779.62-3.92 (-0.50%) ▼|CL86.78-0.22 (-0.25%) ▼|CMCSA23.64-0.78 (-3.20%) ▼|COF201.48-5.38 (-2.60%) ▼|COP132.61-8.62 (-6.10%) ▼|COST894.03-7.32 (-0.81%) ▼|CRM249.94-5.71 (-2.23%) ▼|CSCO107.98-2.09 (-1.90%) ▼|CVS91.61-2.88 (-3.05%) ▼|CVX210.82-6.96 (-3.19%) ▼|DE668.37-15.68 (-2.29%) ▼|DHR208.23-1.13 (-0.54%) ▼|DIS106.59+0.17 (+0.16%) ▲|DUK117.52-0.26 (-0.22%) ▼|EMR145.45-1.55 (-1.05%) ▼|FDX300.53-7.74 (-2.51%) ▼|GD358.75+0.15 (+0.04%) ▲|GE312.44+5.39 (+1.75%) ▲|GEV922.10+39.29 (+4.45%) ▲|GILD147.29+0.99 (+0.67%) ▲|GM84.01-1.36 (-1.59%) ▼|GOOG339.24-2.19 (-0.64%) ▼|GOOGL342.41-2.58 (-0.75%) ▼|GS935.58-41.09 (-4.21%) ▼|HD303.26-2.22 (-0.73%) ▼|HON207.21+3.77 (+1.85%) ▲|IBM236.98-11.40 (-4.59%) ▼|INTC100.14+3.00 (+3.09%) ▲|INTU317.39-11.88 (-3.61%) ▼|ISRG381.58+4.42 (+1.17%) ▲|JNJ267.14-0.07 (-0.02%) ▼|JPM347.37-5.12 (-1.45%) ▼|KO87.88-0.83 (-0.94%) ▼|LIN460.61-2.35 (-0.51%) ▼|LLY1,132.68-3.43 (-0.30%) ▼|LMT534.70+1.24 (+0.23%) ▲|LOW193.97-0.64 (-0.33%) ▼|LRCX267.42-3.45 (-1.27%) ▼|MA567.19-6.08 (-1.06%) ▼|MCD249.70-3.09 (-1.22%) ▼|MDLZ62.44+0.34 (+0.55%) ▲|MDT92.51-1.24 (-1.32%) ▼|META673.07+2.83 (+0.42%) ▲|MMM162.12-2.55 (-1.55%) ▼|MO70.16+0.35 (+0.50%) ▲|MRK144.23+0.44 (+0.31%) ▲|MS201.50-4.78 (-2.32%) ▼|MSFT488.99-8.13 (-1.64%) ▼|MU921.89-5.72 (-0.62%) ▼|NEE80.09-0.99 (-1.22%) ▼|NFLX76.47-1.44 (-1.84%) ▼|NKE35.81-0.42 (-1.15%) ▼|NOW139.27-2.63 (-1.85%) ▼|NVDA213.67+1.50 (+0.71%) ▲|ORCL142.35+2.00 (+1.43%) ▲|PEP134.56-0.94 (-0.69%) ▼|PFE27.40-0.16 (-0.56%) ▼|PG147.28+0.61 (+0.41%) ▲|PLTR172.55-0.01 (0.00%) ▼|PM191.73-2.38 (-1.23%) ▼|QCOM185.52-2.28 (-1.21%) ▼|RTX196.74+1.24 (+0.63%) ▲|SBUX96.89+0.31 (+0.32%) ▲|SCHW105.06-2.73 (-2.53%) ▼|SO85.95+0.00 (+0.00%) ▲|SPG202.04-2.06 (-1.01%) ▼|T25.79-0.93 (-3.48%) ▼|TMO649.40+8.01 (+1.25%) ▲|TMUS173.53-6.94 (-3.85%) ▼|TSLA357.60+1.02 (+0.29%) ▲|TXN259.56-3.87 (-1.47%) ▼|UBER71.36-0.08 (-0.11%) ▼|UNH375.65-0.28 (-0.07%) ▼|UNP280.85-3.14 (-1.11%) ▼|UPS98.65-3.70 (-3.62%) ▼|USB59.62-2.61 (-4.19%) ▼|V369.95-5.68 (-1.51%) ▼|VZ49.60-1.86 (-3.61%) ▼|WFC86.95-2.77 (-3.09%) ▼|WMT107.54-0.55 (-0.51%) ▼|XOM163.34-5.98 (-3.53%) ▼|
25.8 C
New York
Wednesday, September 16, 2026

Tag: loss

New Data for Nusinersen Underscore Biogen’s Commitment to Advancing Clinical Research to Improve Outcomes in SMA

CAMBRIDGE, Mass., June 27, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced new data that reinforce the clinical impact of nusinersen across a broad spectrum of individuals affected by spinal muscular atrophy (SMA). These latest findings from Part C of the DEVOTE trial evaluating a higher dose regimen of nusinersen and the NURTURE trial which evaluated the approved 12 mg regimen (SPINRAZA®) in clinically presymptomatic SMA were presented at the SMA Research & Clinical Care Meeting hosted by Cure SMA in Anaheim, Calif. Biogen’s applications for the higher dose regimen of nusinersen are currently under review in the U.S., Europe, Japan and other global markets. The higher dose regimen of nusinersen comprises a more rapid loading regimen – two 50 mg doses 14 days apart – and a higher maintenance regimen – 28 mg every four months.

ALPHA PRO TECH, LTD. ANNOUNCES $2 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM

NOGALES, Ariz., June 27, 2025 (GLOBE NEWSWIRE) -- – Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced that its Board of Directors has authorized a $2.0 million expansion of the Company’s existing share repurchase program.

Turbo Energy Announces Results of 2025 Annual General Meeting of Shareholders

VALENCIA, Spain, June 27, 2025 (GLOBE NEWSWIRE) -- Turbo Energy, S.A. (NASDAQ:TURB) (“Turbo Energy” or the “Company”), a leader in the field of photovoltaic energy storage, today announced that the following resolutions were approved at its 2025 Annual General Meeting of Shareholders held on June 24, 2024 in Valencia, Spain:

PBK Miner announces zero-fee digital asset management platform for Dogecoin miners in 2025

PBK Miner launches zero-fee platform offering daily profits, flexible contracts and fast withdrawals, making Dogecoin mining open to users worldwide in 2025
PBK Miner launches zero-fee platform offering daily profits, flexible contracts and fast withdrawals, making Dogecoin mining open to users worldwide in 2025

Live Coin Watch Data Reveals Bitcoin Solaris as the Most Undervalued Presale in Crypto History

TALLINN, Estonia, June 27, 2025 (GLOBE NEWSWIRE) -- In a market dominated by noise and recycled narratives, something unexpected has caught the attention of serious crypto watchers. According to fresh data trends and early portfolio analytics on Live Coin Watch, Bitcoin Solaris is now being flagged as the most undervalued presale opportunity in the current cycle. And for once, the data matches the hype.

BAUSCH & LOMB ALERT: Bragar Eagel & Squire, P.C. is Investigating Bausch + Lomb Corporation on Behalf of Bausch & Lomb Stockholders and Encourages...

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Bausch + Lomb Corporation (“Bausch & Lomb” or the “Company”) (NYSE:BLCO) on behalf of Bausch & Lomb stockholders. Our investigation concerns whether Bausch & Lomb has violated the federal securities laws and/or engaged in other unlawful business practices.

PETMED ALERT: Bragar Eagel & Squire, P.C. is Investigating PetMed Express, Inc. on Behalf of PetMed Stockholders and Encourages Investors to Contact the Firm

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) on behalf of PetMed stockholders. Our investigation concerns whether PetMed has violated the federal securities laws and/or engaged in other unlawful business practices.

Prism Pain and Wellness Offering Novel Brain Stimulation to Treat Depression and Optimize Mental Health

ENGLEWOOD, Colo., June 26, 2025 /PRNewswire/ -- The pinnacle of medication-free wellness is now available for those struggling with depression, anxiety and mental fog....

GraniteShares Announces Forward Split of PTIR

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- GraniteShares has announced it will execute a forward share split for the GraniteShares 2x Long PLTR (the “Fund”). The total market value of the shares outstanding will not be affected as a result of these splits.

American Outdoor Brands, Inc. Reports Fourth Quarter and Full Fiscal 2025 Financial Results

•  FY25 Net Sales $222.3 Million – Up 10.6% Y/Y •   FY25 Gross Margin 44.6% – Up 60 Basis Points Y/Y•  FY25 GAAP Net Loss...

Nimanode Presale Skyrockets, over 28% Allocation Scooped as Major Investors Flock to the Potential 10X on XRP

LEEDS, United Kingdom, June 26, 2025 (GLOBE NEWSWIRE) -- The highly anticipated Nimanode (NMA) Presale has so far surpassed expectations, rapidly filling its presale allocation with 28% already scooped so far from its softcap which has fuelled intense investor FOMO.

INVESTMENT OUTLOOK EYES DISCIPLINE AMID VOLATILITY

American Century's chief investment officers' insights on patience amid off-the-charts uncertainty KANSAS CITY, Mo., June 26, 2025 /PRNewswire/ -- Amid a year marked by economic...

Chronic Conditions Surge in U.S. Workforce While Disability Claims Decline, Signaling a New Workforce Health Paradox

OAKLAND, Calif., June 26, 2025 /PRNewswire/ -- More than 78% percent of employees in the US now have at least one chronic condition, an...

No KYC. 100x Leverage. $50 Welcome Bonus. Crypto Futures Trading Made Easy on BexBack

SINGAPORE, June 26, 2025 (GLOBE NEWSWIRE) -- With the price of Bitcoin fluctuating around $100,000, many analysts predict that the cryptocurrency market will remain in a state of high volatility for a long time. Holding spot positions may struggle to generate short-term profits in such conditions. As a result, 100x leverage futures trading has become the preferred tool for seasoned investors looking to maximize potential gains in this volatile market. BexBack Exchange is ramping up its efforts to offer traders unmatched promotional packages. The platform now features a 100% deposit bonus, a $50 welcome bonus for new users, and 100x leverage on cryptocurrency trading, providing exceptional opportunities for investors.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsLoss